Clinical Trial Update: A Study to Evaluate the Effect of Dapagliflozin With and Without Saxagliptin on Albuminuria, and to Investigate the Effect of Dapagliflozin and Saxagliptin on HbA1c in Patients With Type 2 Diabetes and CKD [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating dapagliflozin with and without saxagliptin on albuminuria and HbA1c in patients with type 2 diabetes and chronic kidney disease (CK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albuminuria
• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Saxagliptin (saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus, CKD and Albuminuria | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-06-04